ReviewCurrent pharmaceutical design2026
Electrospun Food Nanofibers for Hormonal Delivery: New Strategy in Sustainable Pharmaceutical Delivery System.
Review in Current pharmaceutical design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrospinning is an innovative process that produces polymeric fibres for a variety of purposes, including controlled hormone administration. These fibres are made from biopolymers like chitosan, cellulose, alginate, and starch, and have attracted interest for their capacity to encapsulate hormones and release them in a regulated way, therefore Increasing bioavailability and stability. The article investigates the utilization of smart electrospun fibers for hormone delivery, alongside a focus on their potential to improve therapeutic results. Electrospun fibres can encapsulate hormones such as insulin, melatonin, and contraceptives for regulated and prolonged release. This method addresses difficulties in traditional hormone delivery, like frequent insulin injections or hormone instability in biological circumstances. Techniques like coaxial electrospinning enable the development of core-shell structures, which further optimize release profiles. The use of these fibres for diabetic management, wound healing, and long-term contraception represents substantial advances in patient care. The flexibility of fibres also allows for precise regulation of drug release kinetics, which improves the efficacy of hormone therapy while reducing adverse effects. Smart electrospun food fibres have enormous promise for the future of hormone administration, providing longer-lasting, more focused, and effective therapies. Their flexibility, along with ongoing advances in electrospinning processes, positions them as a viable tool in contemporary medicine.
Indexed as
Identifiers
40611427What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.